Today’s news reports cover such items as:
- Identification of prostate cancer cells in urine
- Prognosis after radiation therapy
- The effect of bisphenol A on prostate cancer therapy
- The appropriateness of primary androgen deprivation for localized prostate cancer
- Data from clinical trials of Phase II clinical trial of docetaxel + samarium-153 lexidronam and cyclophosphamide + dexamethasone in late stage disease … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, androgen deprivation therapy, bisphenol A, cyclophosphamide, Diagnosis, docetaxel, primary, prognosis, risk, samarium-153 | Leave a Comment »